{"filing":{"accession_number":"0001213900-26-068198","cik":"0001986247","ticker":"BYAH","company_name":"Park Ha Biological Technology Co., Ltd.","form":"6-K","filing_date":"2026-06-12","report_date":null,"primary_document":"ea0294669-6k_parkha.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1986247/000121390026068198/ea0294669-6k_parkha.htm"},"events":[{"id":12159,"run_id":10721,"accession_number":"0001213900-26-068198","anchor_item_number":"EX-99.1","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This press release announces pricing of a registered direct offering of 1,133,332 Class A ordinary shares and pre-funded warrants to purchase 200,000 additional shares, raising approximately $2.0 million gross proceeds. The offering is registered under an effective Form F-3 shelf registration statement and involves dilutive equity issuance to new investors, which is a material capital-raising event that would affect a reasonable investor's assessment of ownership dilution and the company's financial position.","company_name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH","filing_date":"2026-06-12","form":"6-K","submitted_at":null,"items":[{"id":8941,"accession_number":"0001213900-26-068198","item_number":"EX-99.1","item_title":"ea029466901ex99-1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This press release announces pricing of a registered direct offering of 1,133,332 Class A ordinary shares and pre-funded warrants to purchase 200,000 additional shares, raising approximately $2.0 million gross proceeds. The offering is registered under an effective Form F-3 shelf registration statement and involves dilutive equity issuance to new investors, which is a material capital-raising event that would affect a reasonable investor's assessment of ownership dilution and the company's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:20:16.038230+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8941,"accession_number":"0001213900-26-068198","item_number":"EX-99.1","item_title":"ea029466901ex99-1.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This press release announces pricing of a registered direct offering of 1,133,332 Class A ordinary shares and pre-funded warrants to purchase 200,000 additional shares, raising approximately $2.0 million gross proceeds. The offering is registered under an effective Form F-3 shelf registration statement and involves dilutive equity issuance to new investors, which is a material capital-raising event that would affect a reasonable investor's assessment of ownership dilution and the company's financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:20:16.038230+00:00","company_name":"Park Ha Biological Technology Co., Ltd.","ticker":"BYAH","filing_date":"2026-06-12"}]}